Table of Content

1. Introduction


2. Research Methodology


3. Executive Summary


4. Market Dynamics

4.1 Growth Drivers
4.2 Challenges


5. Global Allergic Conjunctivitis Market and Patients Analysis

5.1 Market
5.2 Patient Numbers
5.3 Treated Patient Numbers


6. Share Analysis - Global Allergic Conjunctivitis

6.1 Country Market Share
6.2 Patients Population Share
6.3 Treated Patients Population Share
6.4 By Disease Type Share


7. India – Allergic Conjunctivitis Analysis

7.1 Market
7.2 Patient Numbers
7.3 Treated Patient Numbers


8. China – Allergic Conjunctivitis Analysis

8.1 Market
8.2 Patient Numbers
8.3 Treated Patient Numbers


9. Japan – Allergic Conjunctivitis Analysis

9.1 Market
9.2 Patient Numbers
9.3 Treated Patient Numbers


10. United States – Allergic Conjunctivitis Analysis

10.1 Market
10.2 Patient Numbers
10.3 Treated Patient Numbers


11. United Kingdom – Allergic Conjunctivitis Analysis

11.1 Market
11.2 Patient Numbers
11.3 Treated Patient Numbers


12. France – Allergic Conjunctivitis Analysis

12.1 Market
12.2 Patient Numbers
12.3 Treated Patient Numbers


13. Germany – Allergic Conjunctivitis Analysis

13.1 Market
13.2 Patient Numbers
13.3 Treated Patient Numbers


14. Italy – Allergic Conjunctivitis Analysis

14.1 Market
14.2 Patient Numbers
14.3 Treated Patient Numbers


15. Spain – Allergic Conjunctivitis Analysis

15.1 Market
15.2 Patient Numbers
15.3 Treated Patient Numbers


16. Disease Type – Global Allergic Conjunctivitis Market

16.1 Seasonal Allergic Conjunctivitis (SAC) & Perennial Allergic Conjunctivitis (PAC
16.2 Vernal Keratoconjunctivitis (VKC)
16.3 Atopic Keratoconjunctivitis (AKC)
16.4 Giant Papillary Conjunctivitis (GPC)


17. Global Allergic Conjunctivitis Pipeline Drugs

17.1 Zerviate
17.2 OTX-DP (Dexamethasone Insert)
17.3 ADX-102
17.4 PRT2761
17.5 CVXL-0074
17.6 AK-002
17.7 Bertilimumab
17.8 Reproxalap
17.9 ST-266
17.10 SYL-116011


18. Porters Five Forces

18.1 Overview
18.2 Bargaining Power of Buyers
18.3 Bargaining Power of Suppliers
18.4 Degree of Competition
18.5 Threat of New Entrants
18.6 Threat of Substitutes


19. Company Analysis

19.1 Ocular Therapeutix Inc.

19.1.1 Overview
19.1.2 Recent Development
19.1.3 Revenue

19.2 Portola Pharmaceuticals Inc.

19.2.1 Overview
19.2.2 Recent Development
19.2.3 Revenue

19.3 Alcon

19.3.1 Overvie
19.3.2 Recent Development
19.3.3 Revenue

19.4 Santen Pharmaceutical Co., Ltd.

19.4.1 Overview
19.4.2 Recent Development
19.4.3 Revenue

19.5 Novartis

19.5.1 Overview
19.5.2 Recent Developmen
19.5.3 Revenue



List of Figures

Figure-01: Global – Allergic Conjunctivitis Market (Million US$), 2016 – 2021
Figure-02: Global – Forecast for Allergic Conjunctivitis Market (Million US$), 2022 – 2027
Figure-03: Global – Allergic Conjunctivitis Patient Numbers (Million), 2016 – 2021
Figure-04: Global – Forecast for Allergic Conjunctivitis Patient Numbers (Million), 2022 – 2027
Figure-05: Global – Allergic Conjunctivitis Treated Patient Numbers (Million), 2016 – 2021
Figure-06: Global – Forecast for Allergic Conjunctivitis Treated Patient Numbers (Million), 2022 – 2027
Figure-07: India – Allergic Conjunctivitis Market (Million US$), 2016 – 2021
Figure-08: India – Forecast for Allergic Conjunctivitis Market (Million US$), 2022 – 2027
Figure-09: India – Allergic Conjunctivitis Patient Numbers (Million), 2016 – 2021
Figure-10: India – Forecast for Allergic Conjunctivitis Patient Numbers (Million), 2022 – 2027
Figure-11: India – Allergic Conjunctivitis Treated Patient Numbers (Million), 2016 – 2021
Figure-12: India – Forecast for Allergic Conjunctivitis Treated Patient Numbers (Million), 2022 – 2027
Figure-13: China – Allergic Conjunctivitis Market (Million US$), 2016 – 2021
Figure-14: China – Forecast for Allergic Conjunctivitis Market (Million US$), 2022 – 2027
Figure-15: China – Allergic Conjunctivitis Patient Numbers (Million), 2016 – 2021
Figure-16: China – Forecast for Allergic Conjunctivitis Patient Numbers (Million), 2022 – 2027
Figure-17: China – Allergic Conjunctivitis Treated Patient Numbers (Million), 2016 – 2021
Figure-18: China – Forecast for Allergic Conjunctivitis Treated Patient Numbers (Million), 2022 – 2027
Figure-19: Japan – Allergic Conjunctivitis Market (Million US$), 2016 – 2021
Figure-20: Japan – Forecast for Allergic Conjunctivitis Market (Million US$), 2022 – 2027
Figure-21: Japan – Allergic Conjunctivitis Patient Numbers (Million), 2016 – 2021
Figure-22: Japan – Forecast for Allergic Conjunctivitis Patient Numbers (Million), 2022 – 2027
Figure-23: Japan – Allergic Conjunctivitis Treated Patient Numbers (Million), 2016 – 2021
Figure-24: Japan – Forecast for Allergic Conjunctivitis Treated Patient Numbers (Million), 2022 – 2027
Figure-25: United States – Allergic Conjunctivitis Market (Million US$), 2016 – 2021
Figure-26: United States – Forecast for Allergic Conjunctivitis Market (Million US$), 2022 – 2027
Figure-27: United States – Allergic Conjunctivitis Patient Numbers (Million), 2016 – 2021
Figure-28: United States – Forecast for Allergic Conjunctivitis Patient Numbers (Million), 2022 – 2027
Figure-29: United States – Allergic Conjunctivitis Treated Patient Numbers (Million), 2016 – 2021
Figure-30: United States – Forecast for Allergic Conjunctivitis Treated Patient Numbers (Million), 2022 – 2027
Figure-31: United Kingdom – Allergic Conjunctivitis Market (Million US$), 2016 – 2021
Figure-32: United Kingdom – Forecast for Allergic Conjunctivitis Market (Million US$), 2022 – 2027
Figure-33: United Kingdom – Allergic Conjunctivitis Patient Numbers (Million), 2016 – 2021
Figure-34: United Kingdom – Forecast for Allergic Conjunctivitis Patient Numbers (Million), 2022 – 2027
Figure-35: United Kingdom – Allergic Conjunctivitis Treated Patient Numbers (Million), 2016 – 2021
Figure-36: United Kingdom – Forecast for Allergic Conjunctivitis Treated Patient Numbers (Million), 2022 – 2027
Figure-37: France – Allergic Conjunctivitis Market (Million US$), 2016 – 2021
Figure-38: France – Forecast for Allergic Conjunctivitis Market (Million US$), 2022 – 2027
Figure-39: France – Allergic Conjunctivitis Patient Numbers (Million), 2016 – 2021
Figure-40: France – Forecast for Allergic Conjunctivitis Patient Numbers (Million), 2022 – 2027
Figure-41: France – Allergic Conjunctivitis Treated Patient Numbers (Million), 2016 – 2021
Figure-42: France – Forecast for Allergic Conjunctivitis Treated Patient Numbers (Million), 2022 – 2027
Figure-43: Germany – Allergic Conjunctivitis Market (Million US$), 2016 – 2021
Figure-44: Germany – Forecast for Allergic Conjunctivitis Market (Million US$), 2022 – 2027
Figure-45: Germany – Allergic Conjunctivitis Patient Numbers (Million), 2016 – 2021
Figure-46: Germany – Forecast for Allergic Conjunctivitis Patient Numbers (Million), 2022 – 2027
Figure-47: Germany – Allergic Conjunctivitis Treated Patient Numbers (Million), 2016 – 2021
Figure-48: Germany – Forecast for Allergic Conjunctivitis Treated Patient Numbers (Million), 2022 – 2027
Figure-49: Italy – Allergic Conjunctivitis Market (Million US$), 2016 – 2021
Figure-50: Italy – Forecast for Allergic Conjunctivitis Market (Million US$), 2022 – 2027
Figure-51: Italy – Allergic Conjunctivitis Patient Numbers (Million), 2016 – 2021
Figure-52: Italy – Forecast for Allergic Conjunctivitis Patient Numbers (Million), 2022 – 2027
Figure-53: Italy – Allergic Conjunctivitis Treated Patient Numbers (Million), 2016 – 2021
Figure-54: Italy – Forecast for Allergic Conjunctivitis Treated Patient Numbers (Million), 2022 – 2027
Figure-55: Spain – Allergic Conjunctivitis Market (Million US$), 2016 – 2021
Figure-56: Spain – Forecast for Allergic Conjunctivitis Market (Million US$), 2022 – 2027
Figure-57: Spain – Allergic Conjunctivitis Patient Numbers (Million), 2016 – 2021
Figure-58: Spain – Forecast for Allergic Conjunctivitis Patient Numbers (Million), 2022 – 2027
Figure-59: Spain – Allergic Conjunctivitis Treated Patient Numbers (Million), 2016 – 2021
Figure-60: Spain – Forecast for Allergic Conjunctivitis Treated Patient Numbers (Million), 2022 – 2027
Figure-61: Disease Type – Seasonal Allergic Conjunctivitis (SAC) & Perennial Allergic Conjunctivitis (PAC) Market (Million US$), 2016 – 2021
Figure-62: Disease Type – Forecast for Seasonal Allergic Conjunctivitis (SAC) & Perennial Allergic Conjunctivitis (PAC) Market (Million US$), 2022 – 2027
Figure-63: Disease Type – Vernal Keratoconjunctivitis (VKC) Market (Million US$), 2016 – 2021
Figure-64: Disease Type – Forecast for Vernal Keratoconjunctivitis (VKC) Market (Million US$), 2022 – 2027
Figure-65: Disease Type – Atopic Keratoconjunctivitis (AKC) Market (Million US$), 2016 – 2021
Figure-66: Disease Type – Forecast for Atopic Keratoconjunctivitis (AKC) Market (Million US$), 2022 – 2027
Figure-67: Disease Type – Giant Papillary Conjunctivitis (GPC) Market (Million US$), 2016 – 2021
Figure-68: Disease Type – Forecast for Giant Papillary Conjunctivitis (GPC) Market (Million US$), 2022 – 2027
Figure-69: Ocular Therapeutix Inc. – Global Revenue (Million US$), 2016 – 2021
Figure-70: Ocular Therapeutix Inc. – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-71: Portola Pharmaceuticals Inc. – Global Revenue (Million US$), 2016 – 2021
Figure-72: Portola Pharmaceuticals Inc. – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-73: Alcon – Global Revenue (Million US$), 2016 – 2021
Figure-74: Alcon – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-75: Santen Pharmaceutical Co., Ltd. – Global Revenue (Million US$), 2016 – 2021
Figure-76: Santen Pharmaceutical Co., Ltd. – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-77: Novartis – Global Revenue (Million US$), 2016 – 2021
Figure-78: Novartis – Forecast for Global Revenue (Million US$), 2022 – 2027

List of Tables

Table-01: Global – Allergic Conjunctivitis Market Share by Countries (Percent), 2018 – 2021
Table-02: Global – Forecast for Allergic Conjunctivitis Market Share by Countries (Percent), 2022 – 2027
Table-03: Global – Allergic Conjunctivitis Patients Population Share by Countries (Percent), 2018 – 2021
Table-04: Global – Forecast for Allergic Conjunctivitis Patients Population Share by Countries (Percent), 2022 – 2027
Table-05: Global – Allergic Conjunctivitis Treated Patients Population Share by Countries (Percent), 2018 – 2021
Table-06: Global – Forecast for Allergic Conjunctivitis Treated Patients Population Share by Countries (Percent), 2022 – 2027
Table-07: Global – Allergic Conjunctivitis Market Share by Disease Type (Percent), 2018 – 2021
Table-08: Global – Forecast for Allergic Conjunctivitis Market Share by Disease Type (Percent), 2022 – 2027